U.S. Renewable Energy Stock News

NYSE:AXTA
NYSE:AXTAChemicals

Assessing Whether Axalta Coating Systems (AXTA) Looks Undervalued After Recent Share Price Momentum

What recent performance says about Axalta Coating Systems (AXTA) Axalta Coating Systems (AXTA) has drawn fresh attention after a stretch of mixed share performance, with the stock down about 3.5% year to date but modestly positive over the past year. The stock has also posted gains over the past month and past 3 months, while its longer term 3 year and 5 year total returns remain relatively muted. This has prompted investors to reassess how its current valuation lines up with reported...
NYSE:JBS
NYSE:JBSFood

What JBS (JBS)'s China Beef Import Suspension and Greenpeace Lawsuit Means For Shareholders

In recent months, JBS has faced legal action from Greenpeace in the Netherlands over alleged environmental and human rights failings, while China suspended beef imports from its Vilhena, Brazil plant after detecting a growth hormone. Together, these disputes highlight how regulatory and ethical scrutiny in key export markets can directly challenge JBS’s global expansion plans and operating flexibility. We’ll now examine how the China import suspension, in particular, may reshape JBS’s...
NYSE:BRC
NYSE:BRCCommercial Services

A Look At Brady (BRC) Valuation After Recent Share Price Weakness

Recent trading context for Brady stock Brady (BRC) shares have been under pressure recently, with the stock down 0.2% on the day, 13.5% over the past week, and 3.9% over the past month as investors reassess valuation. See our latest analysis for Brady. The recent 1-day share price return decline of 15.06% sits against a softer 30-day share price return fall of 3.89%, while the 3-year total shareholder return of 61.65% shows that long term holders have still been rewarded. If this kind of...
NasdaqGS:WFRD
NasdaqGS:WFRDEnergy Services

Assessing Weatherford International (WFRD) Valuation After Analysts Lift Fair Value On Margin And Growth Outlook

Weatherford International (WFRD) is back in focus after recent analyst commentary lifted fair value estimates, pointing to a more favorable view on the company’s revenue growth potential, profit margins, and overall earnings profile. See our latest analysis for Weatherford International. The recent analyst update comes after a powerful run in Weatherford International’s stock, with a year to date share price return of 27.33% and a 1 year total shareholder return of 111.80% that points to...
NasdaqGS:EXC
NasdaqGS:EXCElectric Utilities

Does Exelon’s Bigger 2026–2029 Grid Plan Shift the Risk Profile for EXC Investors?

In the first quarter of 2026, Exelon reported revenue and adjusted net income that exceeded expectations and increased year over year, while reaffirming its full-year 2026 earnings outlook. The company also lifted its 2026–2029 capital plan to US$41.70 billion, underscoring a larger grid and infrastructure program that now depends more heavily on regulatory approval and financing conditions. Next, we’ll examine how Exelon’s expanded US$41.70 billion infrastructure plan may reshape its...
NasdaqGS:CBRS
NasdaqGS:CBRSSemiconductor

US Stock Market Today S&P 500 Futures Edge Higher On Strong Jobs Data

The Morning Bull - US Market Morning Update Tuesday, Jun, 9 2026 US stock futures are pointing slightly higher this morning, with E-mini S&P 500 contracts up about 0.2% and Nasdaq-100 minis ahead roughly 0.6%, as investors weigh strong US jobs data against rising borrowing costs. Payrolls in May added 172,000 jobs versus 85,000 expected and the unemployment rate held at 4.3%, a combination that keeps talk of a possible year end interest rate hike alive. At the same time, the 10 year Treasury...
NasdaqCM:ABAT
NasdaqCM:ABATMetals and Mining

American Battery Technology (ABAT) Is Up 6.1% After DOE Reinstates US$115M Grant For Lithium Refinery

American Battery Technology Company recently won its appeal with the U.S. Department of Energy, securing full reinstatement of a US$115 million grant to fund the first phase of its Tonopah Flats Lithium Project refinery, with all technical and commercial milestones preserved and the schedule adjusted for the review-related delay. This decision follows multi-administration federal backing and a Pre-Feasibility Study outlining a long-life lithium project, highlighting sustained government...
NasdaqGS:XERS
NasdaqGS:XERSPharmaceuticals

Should Xeris Biopharma’s Q1 Beat and Director Stock Moves Prompt a Fresh Look From XERS Investors?

In early June 2026, Xeris Biopharma director Marla Persky sold 15,500 shares under a Rule 10b5-1 plan, then received new restricted stock units and stock options as part of the company’s 2018 Stock Option and Incentive Plan. Around the same time, Xeris Biopharma reported a 38% year-on-year increase in Q1 2026 revenue and earnings per share above market expectations, underscoring stronger-than-anticipated operating momentum. Now we’ll examine how Xeris’s better-than-expected Q1 revenue...
NYSE:TBBB
NYSE:TBBBConsumer Retailing

Is BBB Foods’ US$432 Million Equity Raise Reshaping the Expansion Investment Case for TBBB?

In late May 2026, BBB Foods Inc. completed a US$432.39 million follow-on equity offering of 13,304,174 Class A common shares at US$32.50 per share, following a shelf registration filed for the same security. This capital raise, executed at a modest discount, reinforces BBB Foods’ capacity to fund its hard discount expansion in Mexico while broadening its public float. With the follow-on offering now complete, we’ll examine how this fresh equity capital shapes BBB Foods’ expansion-focused...
NasdaqGM:OCC
NasdaqGM:OCCCommunications

A Look At Optical Cable (OCC) Valuation After Its Q2 Return To Profitability

Optical Cable (OCC) is back on investors radar after its latest Q2 earnings reported sales of US$22.21 million and net income of US$1.06 million, compared with a net loss in the same period a year earlier. See our latest analysis for Optical Cable. The sharp 54.47% 1 day share price return after the Q2 release, alongside a 315.75% year to date share price return and very large 1 year total shareholder return, suggests momentum has accelerated as the turnaround in profitability sinks in. If...
NYSE:DCO
NYSE:DCOAerospace & Defense

Ducommun Restatement Probe Tests Accounting Controls And Valuation Opportunity

Ducommun (NYSE:DCO) disclosed a restatement of its 2024 and 2025 financial statements related to stock based compensation expense recognition. A law firm has launched an investigation into potential securities law violations connected to this restatement. The review focuses on whether the company’s accounting and disclosures around equity compensation met regulatory requirements. Ducommun, a long standing supplier to the aerospace, defense, and industrial sectors, now sits under a spotlight...
NYSE:DVN
NYSE:DVNOil and Gas

Will Devon’s Marcellus Sale and Bigger Buyback Shift Devon Energy’s (DVN) Capital Return Narrative?

In recent weeks, Devon Energy advanced its merger with Coterra Energy, moved toward divesting its Marcellus asset after receiving an approximately US$8.00 billion offer, and filed to issue up to 175,000 shares tied to preferred stock conversion. Alongside these changes, Devon announced a new share repurchase authorization exceeding US$5.00 billion and a higher fixed dividend, highlighting a sharper focus on returning cash to shareholders. We’ll now examine how the planned Marcellus...
NasdaqGS:RARE
NasdaqGS:RAREBiotechs

Assessing Ultragenyx Pharmaceutical (RARE) Valuation After UX111 FDA Review Acceptance And Growing GTX-102 Optimism

Ultragenyx Pharmaceutical (RARE) is back in focus after the FDA accepted its resubmitted BLA for UX111, assigning a September 19, 2026 PDUFA date, alongside growing institutional interest in the GTX-102 program. See our latest analysis for Ultragenyx Pharmaceutical. Even with the fresh regulatory progress on UX111 and growing attention on GTX-102, the stock’s momentum has been weak, with the share price down 17.34% over the past 30 days and the 1-year total shareholder return declining...
NYSE:CTRE
NYSE:CTREHealth Care REITs

CareTrust REIT (CTRE) Is Down 6.2% After $1 Billion Market Cap Pullback Amid Solid Operations

Over the past week, CareTrust REIT experienced a prolonged losing streak that erased roughly US$1.00 billion from its market capitalization, even as its operations and balance sheet remain described as robust. This disconnect between weakening market sentiment and the company’s reported underlying strength raises questions about whether recent selling reflects changing fundamentals or short-term investor caution. We’ll now explore how this recent pullback amid otherwise solid operating...
NYSE:ARES
NYSE:ARESCapital Markets

Are Ares Management's New Funding Moves Quietly Redefining Its Fee Engine and Risk Profile (ARES)?

Ares Management recently participated in Goldman Sachs’ 30th Annual European Financials Conference in Zurich, while also advancing initiatives in areas such as student housing and new funding channels through a US$1.00 billion commercial paper program. At the same time, sector-wide swings tied to private credit redemption concerns and renewed interest in alternative assets have highlighted both the resilience and sensitivity of Ares’ fee-based model and fundraising engine. We’ll now examine...
NasdaqGS:SFNC
NasdaqGS:SFNCBanks

Does Simmons First National's (SFNC) Modest Dividend Hike Reveal Its True Capital Priorities?

Simmons First National Corporation recently declared a quarterly cash dividend of US$0.215 per share on its Class A common stock, payable on July 1, 2026, to shareholders of record as of June 15, 2026, representing a 1% increase from the same period last year. This modest dividend increase, alongside differing analyst views on the bank’s outlook and risk profile, has drawn fresh attention to how Simmons balances income returns with ongoing investment and credit considerations. We’ll now...
NasdaqCM:AMPL
NasdaqCM:AMPLSoftware

A Look At Amplitude (AMPL) Valuation As Shares Reflect Mixed Recent Performance

Amplitude (AMPL) has drawn attention after recent trading, with the stock closing at US$7.17 and showing mixed short term moves, including a rise over the past month but declines over the past 3 months and year. See our latest analysis for Amplitude. The recent 1 day share price decline of 6.4% and 7 day share price decline of 18.3% contrast with a 30 day share price return of 12.2%. At the same time, the 1 year total shareholder return decline of 43.5% and 3 year total shareholder return...